Evidence map›Paper›PMID 35987833›Full record

ArticleOrphanet journal of rare diseases2022

Optimising care and follow-up of adults with achondroplasia.

Svein Fredwall, Yana Allum, Moeenaldeen AlSayed, Inês Alves, Tawfeg Ben-Omran, Silvio Boero, Valerie Cormier-Daire, Encarna Guillen-Navarro, Melita Irving, Christian Lampe and 5 more

Open access · goldAbstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Review
  4. Review
  5. Observational
  6. Achondroplasia current concept of orthopaedic management.Journal of children's orthopaedics · 2024
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 11 institutions in 10 countries.

Svein FredwallTRS National Resource Centre for Rare Disorders, Sunnaas Rehabilitation Hospital, Nesodden, Norway. svfred@sunnaas.no.ORCID 0000-0002-2804-5783
Yana AllumIndependent, Perth, WA, Australia.
Moeenaldeen AlSayedDepartment of Medical Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia.
Inês AlvesANDO Portugal, Evora, Portugal.
Tawfeg Ben-OmranDivision of Genetics and Genomic Medicine, Sidra Medicine and Hamad Medical Corporation, Doha, Qatar.
Silvio BoeroPediatric Orthopaedic and Traumatology Unit, Istituto Giannina Gaslini, Genoa, Italy.
Valerie Cormier-DaireCentre of Reference for Constitutional Bone Diseases (MOC), Department of Clinical Genetics, Paris Centre University, INSERM UMR 1163, Imagine Institute, Necker-Enfants Malades Hospital, Paris, France.
Encarna Guillen-NavarroMedical Genetics Section, Department of Pediatrics, Virgen de La Arrixaca University Hospital, IMIB-Arrixaca, University of Murcia-UMU, Murcia, Spain.
Melita IrvingDepartment of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Christian LampeClinic of Neuropediatrics, Epileptology and Social Pediatrics, University Hospital Giessen and Marburg, Giessen, Germany.
Mohamad MaghnieDepartment of Pediatrics, IRCCS Istituto Giannina Gaslini, 16147, Genoa, Italy.
Klaus MohnikeCentral German Competence Network for Rare Diseases (ZSE), Universitätskinderklinik, Otto-Von-Guericke Universität, Magdeburg, Germany.
Geert MortierKU Leuven, Department of Human Genetics and Centre of Human Genetics, UZ Leuven, Leuven, Belgium.
Sérgio B SousaMedical Genetics Unit, Hospital Pediátrico, Centro Hospitalar E Universitário de Coimbra, Coimbra, Portugal.
Michael WrightNewcastle Hospitals, Newcastle, UK.
Istituto Giannina Gaslini · ITAlfaisal University · SAGuy's and St Thomas' NHS Foundation Trust · GBHamad Medical Corporation · QAHospitais da Universidade de Coimbra · PTInserm · FRInstituto de Salud Carlos III · ESSunnaas sykehus · NOUniversitair Ziekenhuis Leuven · BEUniversitätskinderklinik · DEUniversitätsklinikum Gießen und Marburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAchondroplasia is a genetic condition that can cause complications across the lifespan. While complications in childhood are well documented, the natural history of achondroplasia in adults has, until recently, been relatively lacking, and little is known about the care they receive or how they access it. The European Achondroplasia Forum undertook two exploratory surveys, one for healthcare professionals (HCPs) and one for patient advocacy group (PAG) representatives, to gain an understanding of current practices of the transition process of individuals with achondroplasia from paediatric to adult services and how adults perceive their care.

resultsMost HCP respondents followed up more children than adults, and 8/15 responded that individuals did not transition to an adult multidisciplinary team (MDT) after paediatric care. Of 10 PAG respondents, none considered the experience of transition to adult services as good or very good and 50% considered it to be poor or very poor. A total of 64% (7/11) described the coordination of transition to adult services as "Not satisfactory" or "Poor". HCPs and PAG representatives largely agreed on the core specialists involved in adult care (orthopaedic surgeons, physiotherapists, rehabilitation specialists, rheumatologists, clinical geneticists). However, there was a discrepancy in the understanding of healthcare needs outside of this, with PAG representatives selecting neurosurgeons and genetic counsellors, while HCPs selected pulmonologists and obstetricians/gynaecologists. There was agreement between HCP and PAG respondents on the key barriers to effective care of adults with achondroplasia, with lack of an adult MDT, lack of interest from individuals in accessing care, and less experience in adult than paediatric MDTs ranking highly.

conclusionsThis study indicates that the care and follow up of adults with achondroplasia is challenging. Individuals are often lost to, or decline, follow up as they leave paediatric care, and it is largely unknown how, where, and why adults with achondroplasia access care later in life. Lifelong, multidisciplinary specialist care led by an identified physician should be accessible to all individuals with achondroplasia. It is important to ensure barriers to optimal care are addressed to enable access to appropriate care for all individuals with achondroplasia.

Indexed as

AchondroplasiaAdultChildDelivery of Health CareFollow-Up StudiesHumansSurveys and QuestionnairesAchondroplasiaAdultEuropean Achondroplasia ForumGuiding principlesManagementRecommendationsTransition

Identifiers

PMID35987833
PMCPMC9392284
OpenAlexW4292675727

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.